Three biotech IPOs begin trading

The hot offering of the day following yesterday's near-triple in Dicerna Pharmaceuticals (DRNA) is Ultragenyx Pharmaceutical (RARE), which raised $121M after pricing its IPO at $21 each vs. an expected range of $14-$17. The company also upsized the offering amount by 1M shares to 5.8M.

Cara Therapeutics (CARA) raised $55M after selling 5M shares at the low end of the expected $11-$13 range.

Trevena (TRVN) - which two months ago postponed its offering due to market conditions - raised $64.75M after pricing its IPO at $7 per share.

From other sites
Comments (1)
  • misterbsw
    , contributor
    Comment (1) | Send Message
    retired pharmacist. Like to trade options. Long term holding for me is holding until 3:30 PM
    31 Jan 2014, 11:23 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs